95% of Advanced Prostate Cancer Consensus Conference Panellists DO NOT recommend ARPI switch for mCRPC. Yet why do investigators (many of them Panellists) and FDA approve this as control arm for trials?? “Unethical” says ONCODOC from the floor, as did Vinay Prasad MD MPH on GU Cast GU Cast | Urology podcast! #APCCC24

Pierre Blanchard, MD Daniel E Spratt Thomas Hope Louise Emmett Ken Herrmann Advanced Prostate Cancer Consensus Conference Declan Murphy tombal As Dan said, please can we make a point of distinguishing between administered activity and absorbed dose

Chris Parker Pierre Blanchard, MD Daniel E Spratt Thomas Hope Louise Emmett Advanced Prostate Cancer Consensus Conference Declan Murphy tombal We need tons differentiate between injected activity, absorbed normal organ dose and absorbed tumor dose.

Energizing morning at ClevelandZooSociety in support of PanCAN!

Daniel E Spratt 💯 agree. The therapeutic agent is ionising radiation. It's insane that regulators anywhere would allow Lu177 administration to be supervised by non radiation specialists. No fundamental radiobiology knowledge = clinical risk. #radoncdomain

Lovely work from Himanshu Nagar, five fraction prostate bed MRIg SBRT is looking very promising. Can’t wait to see the two year results! #ESTRO24

ARS ROCKET🚀 Join Y. Luh (he/him/dude/他) Thanks for having us, ARS ROCKET🚀 Amer. Radium Society #ars2024. Longer version of the presentation: x.com/nicholaszaorsk…

Ready to heckle, I mean, cheer on Robbie Beckert, #APRT, as he presents data on advanced therapists reducing contouring/on-table times for online ART compared to physicians alone!

Final results of PREVENT Jim Hu Andrew Vickers Edward Schaeffer, MD, PhD shows significant decrease in infection for TP vs TR biopsy (p=0.015). I think we were pretty well powered 😉

Tyler Seibert MD PhD Felix Feng PCF Science Josh Lang Adam Sharp Amar Kishan Daniel E Spratt Howard Soule Himanshu Nagar Sophia Kamran, MD Rana McKay, MD, FASCO Alejandro (Ale) Berlin There is no one—no one—who has had a bigger impact on me, the entire community, and most importantly, patients. Right here with you this morning 🙋‍♂️

🙋🏻‍♀️ What a wonderful celebration for Felix Feng today — >200 scientists from all over the world celebrating his contributions to #prostatecancer. Thank you not enough to Felix Feng’s impact on our 🌎. Thanks for organizing us Paul Nguyen Josh Lang #UCSFBenioffInitiative

Announcement of new Felix Feng Endowed ASCO YIA by President-Elect Eric Small This is amazing. Huge tribute to the super friend, mentor, far-sighted, generous, leader, trailblazer and kindest! #FengSymposium PLEASE DONATE p2p.conquer.org/uniteandconque… Conquer Cancer, the ASCO Foundation

Key prognostic factors in biochemical recurrence (BCR) after primary treatment for prostate cancer. ⭕️Higher pathologic T stage and grade group ⭕️Shorter PSA doubling time (PSADT) ⭕️RNA-based tumor signatures ❌None of the included studies used PET that can detect more metastases

#RADONC twitter poll Trying to understand practice patterns and order requirements for low dose intra nasal sprays (ie analgesia) prior to outpatient nasopharyngoscopy in clinic for HNSCC when used. Outside of any consenting or billing process, does your center require an EMR

Thank you so much!!! So excited and couldn’t have done it without the support of RadOncUH ❤️ Daniel E Spratt Corey Speers Angela Jia Lauren Henke, MD, MSCI #janicelyons

☢️Memorial Sloan Kettering Cancer Center has #radonc positions available on a rolling basis for 2024 & 2025 👉Disease sites: Lung, GU, Gyn, Breast, CNS, & Mets team 👉Locations: Manhattan, NJ, & NY 📍Contact Dr. Daniel Gomez if interested or email: [email protected]

To radoncs of the world, lots of jobs open at MSKCC! Sounds like a very large number needed at many locations. Great for the field that even in urban areas at top centers jobs are available. I am still holding out and on the hunt for a phenomenal team player regional